Literature DB >> 18515363

Interaction of amyotrophic lateral sclerosis (ALS)-related mutant copper-zinc superoxide dismutase with the dynein-dynactin complex contributes to inclusion formation.

Anna-Lena Ström1, Ping Shi, Fujian Zhang, Jozsef Gal, Renee Kilty, Lawrence J Hayward, Haining Zhu.   

Abstract

An important consequence of protein misfolding related to neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS), is the formation of proteinaceous inclusions or aggregates within the central nervous system. We have previously shown that several familial ALS-linked copper-zinc superoxide dismutase (SOD1) mutants (A4V, G85R, and G93A) interact and co-localize with the dynein-dynactin complex in cultured cells and affected tissues of ALS mice. In this study, we report that the interaction between mutant SOD1 and the dynein motor plays a critical role in the formation of large inclusions containing mutant SOD1. Disruption of the motor by overexpression of the p50 subunit of dynactin in neuronal and non-neuronal cell cultures abolished the association between aggregation-prone SOD1 mutants and the dynein-dynactin complex. The p50 overexpression also prevented mutant SOD1 inclusion formation and improved the survival of cells expressing A4V SOD1. Furthermore, we observed that two ALS-linked SOD1 mutants, H46R and H48Q, which showed a lower propensity to interact with the dynein motor, also produced less aggregation and fewer large inclusions. Overall, these data suggest that formation of large inclusions depends upon association of the abnormal SOD1s with the dynein motor. Whether the misfolded SOD1s directly perturb axonal transport or impair other functional properties of the dynein motor, this interaction could propagate a toxic effect that ultimately causes motor neuron death in ALS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18515363      PMCID: PMC2504878          DOI: 10.1074/jbc.M800276200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  60 in total

Review 1.  Neuropathology of ALS: an overview.

Authors:  A Hirano
Journal:  Neurology       Date:  1996-10       Impact factor: 9.910

2.  ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions.

Authors:  L I Bruijn; M W Becher; M K Lee; K L Anderson; N A Jenkins; N G Copeland; S S Sisodia; J D Rothstein; D R Borchelt; D L Price; D W Cleveland
Journal:  Neuron       Date:  1997-02       Impact factor: 17.173

3.  Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis.

Authors:  M E Cudkowicz; D McKenna-Yasek; P E Sapp; W Chin; B Geller; D L Hayden; D A Schoenfeld; B A Hosler; H R Horvitz; R H Brown
Journal:  Ann Neurol       Date:  1997-02       Impact factor: 10.422

4.  Rats expressing human cytosolic copper-zinc superoxide dismutase transgenes with amyotrophic lateral sclerosis: associated mutations develop motor neuron disease.

Authors:  M Nagai; M Aoki; I Miyoshi; M Kato; P Pasinelli; N Kasai; R H Brown; Y Itoyama
Journal:  J Neurosci       Date:  2001-12-01       Impact factor: 6.167

Review 5.  Neuropathology of amyotrophic lateral sclerosis with extra-motor system degeneration: characteristics and differences in the molecular pathology between ALS with dementia and Guamanian ALS.

Authors:  A Ikemoto; A Hirano; I Akiguchi
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2000-03

6.  Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissues.

Authors:  M Watanabe; M Dykes-Hoberg; V C Culotta; D L Price; P C Wong; J D Rothstein
Journal:  Neurobiol Dis       Date:  2001-12       Impact factor: 5.996

7.  Familial amyotrophic lateral sclerosis. Molecular pathology of a patient with a SOD1 mutation.

Authors:  C E Shaw; Z E Enayat; J F Powell; V E Anderson; A Radunovic; S al-Sarraj; P N Leigh
Journal:  Neurology       Date:  1997-12       Impact factor: 9.910

8.  Presence of Cu/Zn superoxide dismutase (SOD) immunoreactivity in neuronal hyaline inclusions in spinal cords from mice carrying a transgene for Gly93Ala mutant human Cu/Zn SOD.

Authors:  N Shibata; A Hirano; M Kobayashi; M C Dal Canto; M E Gurney; T Komori; T Umahara; K Asayama
Journal:  Acta Neuropathol       Date:  1998-02       Impact factor: 17.088

9.  Sporadic amyotrophic lateral sclerosis with dementia and Cu/Zn superoxide dismutase-positive Lewy body-like inclusions.

Authors:  S Matsumoto; H Kusaka; H Ito; N Shibata; T Asayama; T Imai
Journal:  Clin Neuropathol       Date:  1996 Jan-Feb       Impact factor: 1.368

10.  Overexpression of the dynamitin (p50) subunit of the dynactin complex disrupts dynein-dependent maintenance of membrane organelle distribution.

Authors:  J K Burkhardt; C J Echeverri; T Nilsson; R B Vallee
Journal:  J Cell Biol       Date:  1997-10-20       Impact factor: 10.539

View more
  28 in total

1.  A high-throughput screening method for small-molecule inhibitors of the aberrant mutant SOD1 and dynein complex interaction.

Authors:  Xiaohu Tang; Kathleen I Seyb; Mickey Huang; Eli R Schuman; Ping Shi; Haining Zhu; Marcie A Glicksman
Journal:  J Biomol Screen       Date:  2011-12-01

Review 2.  RNA processing pathways in amyotrophic lateral sclerosis.

Authors:  Marka van Blitterswijk; John E Landers
Journal:  Neurogenetics       Date:  2010-03-27       Impact factor: 2.660

Review 3.  Mitochondrial dysfunction in amyotrophic lateral sclerosis.

Authors:  Ping Shi; Jozsef Gal; David M Kwinter; Xiaoyan Liu; Haining Zhu
Journal:  Biochim Biophys Acta       Date:  2009-08-26

4.  Absence of disturbed axonal transport in spinal and bulbar muscular atrophy.

Authors:  Bilal Malik; Niranjanan Nirmalananthan; Lynsey G Bilsland; Albert R La Spada; Michael G Hanna; Giampietro Schiavo; Jean-Marc Gallo; Linda Greensmith
Journal:  Hum Mol Genet       Date:  2011-02-11       Impact factor: 6.150

5.  Endolysosomal Deficits Augment Mitochondria Pathology in Spinal Motor Neurons of Asymptomatic fALS Mice.

Authors:  Yuxiang Xie; Bing Zhou; Mei-Yao Lin; Shiwei Wang; Kevin D Foust; Zu-Hang Sheng
Journal:  Neuron       Date:  2015-07-15       Impact factor: 17.173

Review 6.  Neuroprotection in Oxidative Stress-Related Neurodegenerative Diseases: Role of Endocannabinoid System Modulation.

Authors:  Janos Paloczi; Zoltan V Varga; George Hasko; Pal Pacher
Journal:  Antioxid Redox Signal       Date:  2017-07-18       Impact factor: 8.401

7.  Nuclear localization sequence of FUS and induction of stress granules by ALS mutants.

Authors:  Jozsef Gal; Jiayu Zhang; David M Kwinter; Jianjun Zhai; Hongge Jia; Jianhang Jia; Haining Zhu
Journal:  Neurobiol Aging       Date:  2010-07-31       Impact factor: 4.673

8.  HDAC6 regulates mutant SOD1 aggregation through two SMIR motifs and tubulin acetylation.

Authors:  Jozsef Gal; Jing Chen; Kelly R Barnett; Liuqing Yang; Erin Brumley; Haining Zhu
Journal:  J Biol Chem       Date:  2013-04-11       Impact factor: 5.157

9.  Loss of ALS2/Alsin exacerbates motor dysfunction in a SOD1-expressing mouse ALS model by disturbing endolysosomal trafficking.

Authors:  Shinji Hadano; Asako Otomo; Ryota Kunita; Kyoko Suzuki-Utsunomiya; Akira Akatsuka; Masato Koike; Masashi Aoki; Yasuo Uchiyama; Yasuto Itoyama; Joh-E Ikeda
Journal:  PLoS One       Date:  2010-03-22       Impact factor: 3.240

10.  The legs at odd angles (Loa) mutation in cytoplasmic dynein ameliorates mitochondrial function in SOD1G93A mouse model for motor neuron disease.

Authors:  Ali Morsi El-Kadi; Virginie Bros-Facer; Wenhan Deng; Amelia Philpott; Eleanor Stoddart; Gareth Banks; Graham S Jackson; Elizabeth M C Fisher; Michael R Duchen; Linda Greensmith; Anthony L Moore; Majid Hafezparast
Journal:  J Biol Chem       Date:  2010-04-09       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.